These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3032647)

  • 1. Hybridomas producing human monoclonal antibodies against varicella-zoster virus.
    Sugano T; Matsumoto Y; Miyamoto C; Masuho Y
    Eur J Immunol; 1987 Mar; 17(3):359-64. PubMed ID: 3032647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of monoclonal antibodies against Berne virus (Toroviridae).
    Kaeffer B; van Kooten P; Ederveen J; van Eden W; Horzinek MC
    Am J Vet Res; 1989 Jul; 50(7):1131-7. PubMed ID: 2476050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of neutralizing recombinant human antibodies against Varicella Zoster virus for use as a potential prophylactic.
    Lloyd-Evans P; Gilmour JE
    Hybridoma; 2000 Apr; 19(2):143-9. PubMed ID: 10868794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the cross-reactive antigens between Marek's disease virus and pseudorabies virus by monoclonal antibodies.
    Nakajima K; Kweon CH; An SH; Shibayama T; Wakamiya N; Kato S; Hirai K
    Avian Dis; 1990; 34(2):479-84. PubMed ID: 2164393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain.
    Santos RA; Padilla JA; Hatfield C; Grose C
    Virology; 1998 Sep; 249(1):21-31. PubMed ID: 9740773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
    Møller-Larsen A
    J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines.
    Bourdon-Wouters C; Merville-Louis MP; Sadzot-Delvaux C; Marc P; Piette J; Delrée P; Moonen G; Rentier B
    J Neurosci Res; 1990 May; 26(1):90-7. PubMed ID: 2162972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170.
    Arvin AM; Kinney-Thomas E; Shriver K; Grose C; Koropchak CM; Scranton E; Wittek AE; Diaz PS
    J Immunol; 1986 Aug; 137(4):1346-51. PubMed ID: 3016094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of varicella-zoster virus and herpes simplex virus IgG monoclonal antibodies.
    Hart J; Miller C; Tang X; Vafai A
    J Immunoassay Immunochem; 2009; 30(2):180-5. PubMed ID: 19330643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA).
    Baba K; Yoshida M; Tawa A; Yabuuchi H; Maeda K; Takahashi M
    Biken J; 1984 Mar; 27(1):23-9. PubMed ID: 6091617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
    Keller PM; Lonergan K; Neff BJ; Morton DA; Ellis RW
    J Virol Methods; 1986 Sep; 14(2):177-88. PubMed ID: 3021804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
    J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.